These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6169635)

  • 1. Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation.
    Brenner T; Abramsky O
    Immunol Lett; 1981 Aug; 3(3):163-7. PubMed ID: 6169635
    [No Abstract]   [Full Text] [Related]  

  • 2. A role of alpha-fetoprotein in autoimmune diseases.
    Abramsky O; Brenner T
    Ann N Y Acad Sci; 1983; 417():108-16. PubMed ID: 6200026
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein-rich fractions.
    Brenner T; Zielinski A; Argov Z; Abramsky O
    Tumour Biol; 1984; 5(5):263-74. PubMed ID: 6085187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
    Abramsky O; Brenner T
    Isr J Med Sci; 1979 Nov; 15(11):943-5. PubMed ID: 93589
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T; Beyth Y; Abramsky O
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3635-9. PubMed ID: 6158053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis.
    Zurn AD; Fulpius BW
    Eur J Immunol; 1977 Aug; 7(8):529-32. PubMed ID: 902680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Qiao J; Olsson T; Huang WX
    J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.
    Heilbronn E; Lefvert AK; Stålberg E
    Muscle Nerve; 1978; 1(5):427-31. PubMed ID: 263985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors in the production of experimental autoimmune myasthenia gravis in acetylcholine receptor immunized rabbits.
    Niemi WD; Nastuk WL; Chang HW; Plescia OJ; Plescia AM
    Ann N Y Acad Sci; 1981; 377():222-36. PubMed ID: 6951475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides.
    Souroujon MC; Carmon S; Fuchs S
    Immunol Lett; 1992 Sep; 34(1):19-25. PubMed ID: 1282497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological studies of thymectomized and nonthymectomized acetylcholine receptor-immunized animal models of myasthenia gravis.
    Niemi WD; Nastuk WL; Chang HW; Penn AS; Rosenberry TL
    Exp Neurol; 1979 Jan; 63(1):1-27. PubMed ID: 223859
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of monoclonal antibodies to study acetylcholine receptors from electric organs, muscle, and brain and the autoimmune response to receptor in myasthenia gravis.
    Lindstrom J; Tzartos S; Gullick W; Hochschwender S; Swanson L; Sargent P; Jacob M; Montal M
    Cold Spring Harb Symp Quant Biol; 1983; 48 Pt 1():89-99. PubMed ID: 6586364
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine.
    Abramsky O; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1976 Jul; 117(1):225-8. PubMed ID: 932425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
    Christadoss P; Shenoy M; Oshima M; Atassi MZ
    Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.